ArticleInternational urology and nephrology2023

Circulating tumor cell quantification during abiraterone plus prednisone therapy may estimate survival in metastatic castration-resistant prostate cancer patients.

Tengfei Gu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.